Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, shared a post on LinkedIn:
“Interesting presentation during Metastatic Breast Cancer session on how AI-assisted support led to increased accuracy and pathologist’s concordance in interpretation of HER2 IHC score, particularly in cases of HER2-low and ultralow cases.”
More posts featuring ASCO25.
